Drugs

Bosutinib

Bosutinib Brand Name– BOSULIF What is Bosutinib Bosutinib is an oral multi-tyrosine kinase inhibitor that works by inhibiting Bcr-Abl and Src family kinases. Bosutinib is indicated for the treatment of adult patients with newly diagnosed chronic phase (CP) Philadelphia chromosome-positive (Ph+ CML) and CP, accelerated phase (AP), or blast phase (BP) Ph+ CML with resistance …

Bosutinib Read More »

Bosentan

Bosentan Brand Name– Tracleer What is Bosentan Bosentan is a cardiovascular agent that belongs to a group of compounds known as endothelin-receptor antagonists and is indicated for use in pulmonary arterial hypertension in patients with WHO Class II to IV symptoms. It is a specific and competitive antagonist at both type A and B endothelin-1 …

Bosentan Read More »

Bortezomib

Bortezomib Brand Name– Velcade What is Bortezomib Bortezomib is a proteasome inhibitor; it was the first compound in this class to reach clinical trials and receive FDA-approval. Bortezomib is approved for the treatment of multiple myeloma and mantle-cell lymphoma. It may be administered as an IV bolus injection; Velcade is the only formulation approved for …

Bortezomib Read More »

Boric Acid

Boric Acid Brand Name– Hylafem What is Boric Acid Boric acid is available as an ophthalmic solution and a vaginal suppository. The ophthalmic solution is used as an irrigation for irritated eyes and to remove foreign materials from the eyes. The vaginal suppository is used to treat the symptoms of vulvovaginal candidiasis. There is a …

Boric Acid Read More »

Boceprevir

Boceprevir Brand Name– VICTRELIS What is Boceprevir Boceprevir is a hepatitis C virus (HCV) NS3/4A protease inhibitor. It is indicated for the treatment of genotype 1 chronic HCV infection in adults with compensated liver disease (including cirrhosis) who are treatment-naive or who have previously had no or an inadequate responded to interferon/ribavirin therapy (i.e., null …

Boceprevir Read More »

Blinatumomab

Blinatumomab Brand Name– Blincyto What is Blinatumomab Blinatumomab is a CD3 T-cell engager that binds to CD19 expressed on the surface of B-cell precursors and to CD3 expressed on the surface of T cells. It is indicated in adults and pediatric patients for the treatment B-cell precursor acute lymphoblastic leukemia in patients with relapsed or …

Blinatumomab Read More »

15585

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

15856